Scotiabank Initiates Coverage On Skye Bioscience with Sector Outperform Rating, Announces Price Target of $20
Portfolio Pulse from Benzinga Newsdesk
Scotiabank has initiated coverage on Skye Bioscience with a Sector Outperform rating and set a price target of $20.
September 30, 2024 | 1:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank has initiated coverage on Skye Bioscience with a Sector Outperform rating and a price target of $20, indicating a positive outlook.
The initiation of coverage with a Sector Outperform rating and a $20 price target by Scotiabank suggests a positive outlook for Skye Bioscience. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100